Market Momentum Report: Ginkgo Bioworks Holdings Inc (DNA)’s Negative Close at 11.20

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $11.20 in the last session, down -3.86% from day before closing price of $11.65. In other words, the price has decreased by -$3.86 from its previous closing price. On the day, 1.51 million shares were traded. DNA stock price reached its highest trading level at $12.75 during the session, while it also had its lowest trading level at $11.2.

Ratios:

We take a closer look at DNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.56.

Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 07 ’25 when Che Austin bought 99 shares for $11.77 per share.

Dmytruk Mark E. bought 645 shares of DNA for $7,558 on Jan 06 ’25. On Jan 06 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $11.70 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 643763648 and an Enterprise Value of 439541728. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.95 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at 2.017 whereas that against EBITDA is -0.836.

Stock Price History:

Over the past 52 weeks, DNA has reached a high of $64.40, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is 25.46%, while the 200-Day Moving Average is calculated to be -32.81%.

Shares Statistics:

According to the various share statistics, DNA traded on average about 1.22M shares per day over the past 3-months and 1470270 shares per day over the past 10 days. A total of 41.37M shares are outstanding, with a floating share count of 36.49M. Insiders hold about 33.02% of the company’s shares, while institutions hold 47.96% stake in the company. Shares short for DNA as of 1734048000 were 7173693 with a Short Ratio of 5.87, compared to 1731628800 on 7315814. Therefore, it implies a Short% of Shares Outstanding of 7173693 and a Short% of Float of 21.55.

Most Popular